The study, launched in partnership with medical technology vendor Bay Labs, will assess whether one of the company’s investigational AI tools can help certified medical assistants perform high-quality echocardiograms, or sonograms of the heart, even if they don’t have previous scanning experience.
The tool, EchoGPS, is a cardiac ultrasound guidance software that walks certified medical assistants through how to capture echocardiograms in real-time. It pairs with another tool, EchoMD, which uses AI to help cardiologists interpret these images to detect heart disease among patients 65 years and older.
In total, the study will enroll an estimated 1,200 patients at Northwestern Medicine’s primary care sites. Researchers in the study will evaluate whether the tools enable detection of more patients with heart disease in the primary care setting, compared to standard physical exams with electrocardiograms.
The study is part of Bay Labs’ ongoing partnership with Northwestern Medicine, exploring various ways to apply AI to cardiovascular care. It also falls under the umbrella of Northwestern Medicine’s larger cardiovascular AI initiative, which the health system revealed plans for in June.
More articles on artificial intelligence:
Amazon adds 3 ‘HIPAA-eligible’ AI tools to cloud service
New AI model from UCSF can detect Alzheimer’s 6 years before diagnosis
AI outperforms cardiologists in detecting heart murmurs, study suggests
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
